MedPath
NMPA Approval

Doxifluridine Capsules

国药准字H20010180

March 10, 2020

Drug Information

去氧氟尿苷胶囊

奇诺必通

奇诺必通

胶囊剂

0.2g

化学药品

March 10, 2020

Company Information

Applicant Company

Manufacturing Company

淄博市博山经济技术开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

去氧氟尿苷胶囊 - NMPA 批准文号 | MedPath